BioMarin Pharmaceutical Profile

USD 0.13  0.15%
80.76Last Month High 88.66 
88.22Trading Day  High 90.0 

Exercise or conversion by Pierre Lapalme of 100 shares of BioMarin Pharmaceutical subject to Rule 16b-3

BioMarin Pharmaceutical Inc insider trading alert for exercise of stock option (right to buy) by Pierre Lapalme, the corporate stakeholder, on December 9, 2017. This event was filed by Biomarin Pharmaceutical I with SEC on 2011-02-24. Statement of changes in beneficial ownership - SEC Form 4. Pierre Lapalme is currently serves as independent chairman of the board of BioMarin Pharmaceutical [view details]   

BioMarin Pharmaceutical Summary

BioMarin Pharmaceutical Inc (BMRN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 2,158 people. BioMarin Pharmaceutical is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with current market capitalization of 14.4 B. BioMarin Pharmaceutical Inc conducts business under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 175.62 M outstanding shares of which 9.03 M shares are currently shorted by private and institutional investors with about 5.81 trading days to cover. BIOMARIN PHARMACE currently holds about 1.26 B in cash with (23.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.16.
Check BioMarin Pharmaceutical Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Capital Research Global InvestorsCommon Shares20.9 M1.9 B
Vanguard Group IncCommon Shares14.6 M1.4 B
View BioMarin Pharmaceutical Diagnostics

Selected BioMarin Pharmaceutical Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

BioMarin Pharmaceutical Against Markets

Current Ratings  

BioMarin Pharmaceutical 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
< 6% 
BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameBioMarin Pharmaceutical Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock Stocks Directory
RegionNorth America
Business Address770 Lindaro Street, San Rafael, CA 94901, United States
CIK Number01048477.0
IndustryPharmaceuticals And Biosciences
Contact Number415 506 6700
CurrencyUSD - US Dollar

Current Sentiment - BMRN

BioMarin Pharmaceutical Investor Sentiment
Most of Macroaxis users are currently bullish on BioMarin Pharmaceutical Inc. What is your opinion about investing in BioMarin Pharmaceutical Inc? Are you bullish or bearish?
98% Bullish
2% Bearish
BMRNSkip  Hide


BioMarin Pharmaceutical Analyst Recommendations
Target PriceAdvice# of Analysts
BioMarin Pharmaceutical Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
BioMarin Pharmaceutical Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


BioMarin Pharmaceutical Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.29April 27, 2017
BioMarin Pharmaceutical Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate